Direclidine (INN; developmental code names NBI-1117568, HTL-0016878) is an investigational antipsychotic drug for schizophrenia that was out-licensed from Nxera Pharma to Neurocrine Biosciences, a United States-based pharmaceutical company.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.